(Q33150747)
Statements
1 reference
Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: magnetic resonance imaging evidence for altered tumor blood flow (English)
1 reference
James P Stevenson
1 reference
Mark Rosen
1 reference
Weijing Sun
1 reference
Maryann Gallagher
1 reference
Daniel G Haller
1 reference
David Vaughn
1 reference
Bruce Giantonio
1 reference
Ross Zimmer
1 reference
William P Petros
1 reference
Michael Stratford
1 reference
David Chaplin
1 reference
Scott L Young
1 reference
Mitchell Schnall
1 reference
Peter J O'Dwyer
1 reference
1 December 2003
1 reference
1 reference
21
1 reference
23
1 reference
4428-4438
1 reference
Identifiers
1 reference
1 reference